Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-10T06:19:18.483Z Has data issue: false hasContentIssue false

Variation in antibiotic use across intensive care units (ICU): A population-based cohort study in Ontario, Canada

Published online by Cambridge University Press:  16 June 2020

Erika Y. Lee
Affiliation:
Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Michael E. Detsky
Affiliation:
Department of Medicine, University of Toronto, Toronto, Ontario, Canada Department of Medicine, Sinai Health System, Toronto, Ontario, Canada Interdepartmental Division of Critical Care Medicine, Sinai Health System, Toronto, Ontario, Canada
Jin Ma
Affiliation:
Biostatistics Research Unit, University Health Network, Toronto, Ontario, Canada
Chaim M. Bell
Affiliation:
Department of Medicine, University of Toronto, Toronto, Ontario, Canada Department of Medicine, Sinai Health System, Toronto, Ontario, Canada Department of Medicine, University Health Network, Toronto, Ontario, Canada
Andrew M. Morris*
Affiliation:
Department of Medicine, University of Toronto, Toronto, Ontario, Canada Department of Medicine, Sinai Health System, Toronto, Ontario, Canada Department of Medicine, University Health Network, Toronto, Ontario, Canada
*
Author for correspondence: Andrew M. Morris, E-mail: Andrew.Morris@sinaihealthsystem.ca

Abstract

Objectives:

Antibiotics are commonly used in intensive care units (ICUs), yet differences in antibiotic use across ICUs are unknown. Herein, we studied antibiotic use across ICUs and examined factors that contributed to variation.

Methods:

We conducted a retrospective cohort study using data from Ontario’s Critical Care Information System (CCIS), which included 201 adult ICUs and 2,013,397 patient days from January 2012 to June 2016. Antibiotic use was measured in days of therapy (DOT) per 1,000 patient days. ICU factors included ability to provide ventilator support (level 3) or not (level 2), ICU type (medical-surgical or other), and academic status. Patient factors included severity of illness using multiple-organ dysfunction score (MODS), ventilatory support, and central venous catheter (CVC) use. We analyzed the effect of these factors on variation in antibiotic use.

Results:

Overall, 269,351 patients (56%) received antibiotics during their ICU stay. The mean antibiotic use was 624 (range 3–1460) DOT per 1,000 patient days. Antibiotic use was significantly higher in medical-surgical ICUs compared to other ICUs (697 vs 410 DOT per 1,000 patient days; P < .0001) and in level 3 ICUs compared to level 2 ICUs (751 vs 513 DOT per 1,000 patient days; P < .0001). Higher antibiotic use was associated with higher severity of illness and intensity of treatment. ICU and patient factors explained 47% of the variation in antibiotic use across ICUs.

Conclusions:

Antibiotic use varies widely across ICUs, which is partially associated with ICUs and patient characteristics. These differences highlight the importance of antimicrobial stewardship to ensure appropriate use of antibiotics in ICU patients.

Type
Original Article
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Pakyz, A, Powell, JP, Harpe, SE, et al.Diversity of antimicrobial use and resistance in 42 hospitals in the United States. Pharmacotherapy 2008;28:906912.10.1592/phco.28.7.906CrossRefGoogle ScholarPubMed
Spellberg, B, Guidos, R, Gilbert, Det al.The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008;46:155164.10.1086/524891CrossRefGoogle Scholar
Cosgrove, SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006;15 suppl 2:S82S89.10.1086/499406CrossRefGoogle Scholar
Richards, MJ, Edwards, JR, Culver, DH, et al. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999;27:887892.10.1097/00003246-199905000-00020CrossRefGoogle Scholar
Kollef, MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000;31 suppl 4:S131S138.10.1086/314079CrossRefGoogle ScholarPubMed
Denisuik, AJ, Garbutt, LA, Golden, AR, et al.Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study. J Antimicrob Chemother 2019;74:645653.10.1093/jac/dky477CrossRefGoogle ScholarPubMed
Luyt, CE, Brechot, N, Trouillet, JL, et al.Antibiotic stewardship in the intensive care unit. Crit Care 2014;18:480.10.1186/s13054-014-0480-6CrossRefGoogle ScholarPubMed
Vincent, JL, Rello, J, Marshall, J, et al.International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:23232329.10.1001/jama.2009.1754CrossRefGoogle Scholar
Hurford, A, Morris, AM, Fisman, DN, et al.Linking antimicrobial prescribing to antimicrobial resistance in the ICU: before and after an antimicrobial stewardship program. Epidemics 2012;4:203210.10.1016/j.epidem.2012.12.001CrossRefGoogle ScholarPubMed
Barlam, TF, Cosgrove, SE, Abbo, LM, et al.Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62:e51e77.10.1093/cid/ciw118CrossRefGoogle Scholar
Morris, AM, Bai, A, Burry, L, et al.Long-term effects of phased implementation of antimicrobial stewardship in academic ICUs: 2007–2015. Crit Care Med 2019;47:159166.10.1097/CCM.0000000000003514CrossRefGoogle ScholarPubMed
Lindsay, PJ, Rohailla, S, Taggart, LR, et al.Antimicrobial stewardship and intensive care unit (ICU) mortality: a systematic review. Clin Infect Dis 2019;68:748756.10.1093/cid/ciy550CrossRefGoogle ScholarPubMed
Tan, C, Vermeulen, M, Wang, X, et al.Variability in antibiotic use across Ontario acute-care hospitals. J Antimicrob Chemother 2017;72:554563.10.1093/jac/dkw454CrossRefGoogle ScholarPubMed
Daneman, N, Bronskill, SE, Gruneir, A, et al.Variability in antibiotic use across nursing homes and the risk of antibiotic-related adverse outcomes for individual residents. JAMA Intern Med 2015;175:13311339.10.1001/jamainternmed.2015.2770CrossRefGoogle ScholarPubMed
Schwartz, KL, Achonu, C, Brown, KA, et al.Regional variability in outpatient antibiotic use in Ontario, Canada: a retrospective cross-sectional study. CMAJ Open 2018;6:E445E452.10.9778/cmajo.20180017CrossRefGoogle ScholarPubMed
Daneman, N, Gruneir, A, Bronskill, SE, et al.Prolonged antibiotic treatment in long-term care: role of the prescriber. JAMA Intern Med 2013;22;173:673682.10.1001/jamainternmed.2013.3029CrossRefGoogle Scholar
Dellit, TH, Owens, RC, McGowan, JE Jr, et al.Infectious Diseases Society of America; Society for Healthcare Epidemiology of America: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159177.10.1086/510393CrossRefGoogle Scholar
2016 Census. Statistics Canada website. https://www12.statcan.gc.ca/census-recensement/index-eng.cfm. Published 2019. Accessed December 15, 2018.Google Scholar
About us. Council of Academic Hospitals of Ontario (CAHO) website. http://caho-hospitals.com/about-us/. Accessed August 22, 2019.Google Scholar
Marshall, JC, Cook, DJ, Christou, NV, et al.Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995;23:16381652.10.1097/00003246-199510000-00007CrossRefGoogle ScholarPubMed
Polk, RE, Hohmann, SF, Medvedev, S, et al.Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals. Clin Infect Dis 2011;53:11001110.10.1093/cid/cir672CrossRefGoogle ScholarPubMed
Morris, AM, Brener, S, Dresser, L, et al.Use of a structured panel process to define quality metrics for antimicrobial stewardship programs. Infect Control Hosp Epidemiol 2012;33:500506.10.1086/665324CrossRefGoogle ScholarPubMed
Morris, AM. Antimicrobial stewardship programs: appropriate measures and metrics to study their impact. Curr Treat Options Infect Dis 2014;6:101112.10.1007/s40506-014-0015-3CrossRefGoogle ScholarPubMed
Care in Canadian ICUs. Canadian Institute for Health Information website. https://secure.cihi.ca/free_products/ICU_Report_EN.pdf. Published 2016. Accessed September 30, 2019.Google Scholar
MacDougall, C, Polk, RE. Variability in rates of use of antibacterials among 130 US hospitals and risk-adjustment models for interhospital comparison. Infect Control Hosp Epidemiol 2008;29:203211.10.1086/528810CrossRefGoogle ScholarPubMed
Meyer, E, Schwab, F, Gastmeier, P, et al.Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004. Infection 2006;34:303309.10.1007/s15010-006-6619-xCrossRefGoogle ScholarPubMed
Polk, RE, Fox, C, Mahoney, A, et al.Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis 2007;44:664670.10.1086/511640CrossRefGoogle ScholarPubMed
De Bus, L, Gadeyne, B, Steen, J, et al.A complete and multifaceted overview of antibiotic use and infection diagnosis in the intensive care unit: results from a prospective four-year registration. Crit Care 2018;29;22:241.10.1186/s13054-018-2178-7CrossRefGoogle Scholar
Kollef, MH, Golan, Y, Micek, ST, et al.Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections—proceedings and data from the Gram-Negative Resistance Summit. Clin Infect Dis 2011;53 suppl 2:S33S55.10.1093/cid/cir475CrossRefGoogle ScholarPubMed
Savage, RD, Fowler, RA, Rishu, AH, et al.The effect of inadequate initial empiric antimicrobial treatment on mortality in critically ill patients with bloodstream infections: a multi-centre retrospective cohort study. PloS One 2016;11(5):e0154944.10.1371/journal.pone.0154944CrossRefGoogle ScholarPubMed
Dresser, LD, Bell, CM, Steinberg, M, et al.Use of a structured panel process to define antimicrobial prescribing appropriateness in critical care. J Antimicrob Chemother 2018;73:246249.10.1093/jac/dkx341CrossRefGoogle ScholarPubMed
Baggs, J, Fridkin, SK, Pollack, LA, et al.Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012. JAMA Intern Med 2016;176:16391648.10.1001/jamainternmed.2016.5651CrossRefGoogle ScholarPubMed
Jeffs, L, Thampi, N, Maione, M, et al.A qualitative analysis of implementation of antimicrobial stewardship at 3 academic hospitals: understanding the key influences on success. Can J Hosp Pharm 2015;68:395400.Google ScholarPubMed
Supplementary material: File

Lee et al. supplementary material

Lee et al. supplementary material

Download Lee et al. supplementary material(File)
File 247.5 KB